Kelpi lands $5.5M investment to get algae-based biomaterials to market

In the UK, in a huge step forward for the business, Kelpi has secured £4.35 million ($5.5m) in investment to take its pioneering biomaterial technology to market. The funding round will fund the next chapter for the business, allowing it to expand operations, grow the team and run scale-up pilots to plot its pathway to launch.

Kelpi’s equity funding round was led by Blackfinch Ventures, with funding from Green Angel Ventures, Kadmos Capital, QantX, Evenlode Foundation and the South West Investment Fund as well as follow-on investment from Bristol Private Equity Club (BPEC), One Planet Capital and private angel investors. Having initially sought £3m in equity investment, raising £4.35m constitutes a significant success for Kelpi.

The funds will be used to advance manufacturing pilots and gain regulatory approval for our proprietary coatings for paper and card as well as continue a commercial roll-out which has already seen us win R&D contracts with global leaders like L’Oréal, Diageo, and Waitrose and their tropical fresh fruit supplier Blue Skies.